Barclays
AEHR icon

Barclays’s Aehr Test Systems AEHR Stock Holding History

Barclays’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-211,800
Closed -$4.26M – 5064
2022
Q4 		$4.26M Buy
+211,800
New +$4.53M ﹤0.01% 1739

Other funds holding AEHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's AEHR Position: Q1 2026 in Review

Barclays increased its Aehr Test Systems (AEHR) stake by 18% in Q1 2026, buying an estimated $251K and bringing the position to 52,214 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2372.

Barclays first reported a position in AEHR in Q3 2021 and has held it in 17 quarters since. The position peaked at $2.44M in Q4 2022. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

  • Barclays held 52,214 shares of Aehr Test Systems worth $1.94M as of Q1 2026.
  • Barclays bought 7,834 Aehr Test Systems shares in Q1 2026, an estimated $251K.
  • Aehr Test Systems made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2372 holding.
  • Barclays first reported a position in Aehr Test Systems in Q3 2021 and has held it in 17 quarters since.
  • Barclays's Aehr Test Systems position peaked at $2.44M in Q4 2022.
  • 191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.